On June 15, 2026, China's National Medical Products Administration(NMPA) released two draft mandatory national standards for public consultation: Evaluation Criteria and Management Principles for Cosmetic Cheilitis and Evaluation Criteria and Management Principles for Cosmetic Contact Urticaria. The consultation period runs from June 15 to August 15, 2026. Since the implementation of the Cosmetic Supervision and Administration Regulation(CSAR) in 2021, China has established a cosmetic adverse reaction monitoring system. The Measures for the Management of Cosmetic Adverse Reaction Monitoring further introduced the principle of “suspected cases should be reported.” However, unified national criteria for determining specific types of adverse
